Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Urticaria
ADR ID BADD_A04469
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.06      Urticarias
10.01.06.001      Urticaria
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.02      Urticarias
23.04.02.001      Urticaria
Description A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins. [CTCAE] A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. [MeSH]
MedDRA Code 10046735
MeSH ID D014581
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic urticaria | Acute urticaria | Allergic urticaria | Erythema urticarial | Generalised urticarial | Generalised urticarial rash | Histamine-like rash | Hives | Nettle rash | Other specified urticaria | Pharmacological urticaria | Rash urticaria-like | Rash urticarial | Subcutaneous urticaria | Unspecified urticaria | Urticaria | Urticaria acute | Urticaria aggravated | Urticaria NOS | Urticaria subcutaneous | Urticaria, unspecified | Urticarial | Urticarial rash | Urticarial symptom | Urticated rash | Urtication | Welts | Wheals | Generalized urticaria | Urticaria generalised | Urticaria drug-induced | Urticaria localised | Urticaria localized | Generalized urticarial rash | Urticaria recurrent | Generalised urticaria | Atopic urticaria | Urticarias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01515Nafcillin0.000355%
BADD_D01516Nafcillin sodium--
BADD_D01519Nalbuphine--
BADD_D01520Nalbuphine hydrochloride--
BADD_D01521Nalidixic acid--
BADD_D01527Naltrexone--
BADD_D01530Nandrolone decanoate--
BADD_D01533Naproxen0.000436%
BADD_D01534Naproxen sodium--
BADD_D01535Naratriptan--
BADD_D01536Naratriptan hydrochloride--
BADD_D01537Natalizumab--
BADD_D01539Nateglinide--
BADD_D01541Nebivolol0.000585%
BADD_D01542Nebivolol hydrochloride--
BADD_D01544Nedocromil--
BADD_D01546Nefazodone--
BADD_D01547Nefazodone hydrochloride--
BADD_D01550Nelfinavir mesylate--
BADD_D01553Neostigmine--
BADD_D01554Neostigmine methylsulfate--
BADD_D01555Nepafenac0.000794%
BADD_D01557Nevirapine--
BADD_D01558Nexium--
BADD_D01559Niacin0.001945%
BADD_D01563Nicotinate--
BADD_D01564Nicotine0.008713%
BADD_D01566Nifedipine0.001127%
BADD_D01567Nilotinib--
BADD_D01570Nisoldipine--
The 29th Page    First    Pre   29 30 31 32 33    Next   Last    Total 45 Pages
ADReCS-Target
ADR Term Drug Name Target